Opening the mysteries of drug actions, discovering new therapies, and developing new medicinal products

Cardiovascular regulation, cell signaling, structural and cancer biology, and environmental toxicology are just a few interests of the faculty at the Department of Pharmacology at the University of Vermont.

Students interested in the interaction of chemical substance with biological systems will benefit from direct contact with faculty researchers. Studies in Pharmacology at the College of Medicine serve medical and graduate students, post-doctoral trainees and undergraduates.

Learn more about Pharmacology as a Career sponsored by the American Society for Pharmacology & Experimental Therapeutics (ASPET).

Learn more about careers for scientists from the Science Careers Site sponsored by the American Association for the Advancement of Science.

 

 

Graduate students and poster

Graduate Studies

The Pharmacology Department has joined the Cellular and Molecular Biology Graduate Program for those Graduates interested in pursuing a Ph.D. The Pharmacology Department offers both a Thesis Research based Masters in Pharmacology and a Non-Thesis Masters  in Pharmacology. Exclusively for UVM students we offer an Accelerated Masters Program. We also offer an undergraduate 15-credit minor, course offerings include Toxicology, Molecular and Cellular Pharmacology, Pharmacological Techniques and Medicinal Chemistry.

Researcher in a lab

Pharmacology Research

  • Brain and cerebral vascular studying the blood flow to the brain.
  • Cardiovascular Pharmacology and Physiology
  • Signal transduction
  • Medicinal chemistry/cancer chemotherapy

Faculty giving presentation

Seminars

As the host of the weekly Seminar Series and the annual trustees visit and retreat, the Pharmacology department has an active schedule of seminars and events.

 

Recent News

Lounsbury Highlighted in Forbes Article about UVM Medicinal Marijuana Course

July 21, 2017 by Madi Wood

On July 21, 2017, UVM Professor of Pharmacology, Karen Lounsbury, Ph.D. spoke with Forbes about the United States' first-ever 'higher learning' course on medicinal marijuana "Pharm 200: Cannabis, Past, Present and Future" - a course that she co-designed.

Karen Lounsbury, Ph.D., pharmacology professor of and researcher

"Considering the ongoing impact of the opioid epidemic and cannabis' potential as both a major industry and a safer, often far cheaper treatment for various medical conditions, Lounsbery's small risk in bringing cannabis science to academia seems like the right kind to take: Thoughtful, constructive, and evidence-based." - Janet Burns, Forbes Contributor

In a July 21, 2018 Forbes article about UVM's medicinal marijuana course "Cannabis Past, Present, and Future," UVM Professor of Pharmacology and co-designer of the class, Karen Lounsbury, Ph.D., spoke about the structure of the course, the red tape involved in researching cannabis materials, and cannabis as a potential replacement pain-killer for opioid patients.

Read the full article at Forbes.com.